These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 16048969

  • 1. In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.
    Yustes C, Guarro J.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3498-500. PubMed ID: 16048969
    [Abstract] [Full Text] [Related]

  • 2. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K, Tredup A, Salvenmoser S, Müller FM.
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [Abstract] [Full Text] [Related]

  • 3. In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus.
    Serena C, Fernández-Torres B, Pastor FJ, Trilles L, Lazéra Mdos S, Nolard N, Guarro J.
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2994-6. PubMed ID: 15980382
    [Abstract] [Full Text] [Related]

  • 4. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A.
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [Abstract] [Full Text] [Related]

  • 5. In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula.
    Serena C, Mariné M, Pastor FJ, Nolard N, Guarro J.
    J Antimicrob Chemother; 2005 Jun; 55(6):1020-3. PubMed ID: 15845779
    [Abstract] [Full Text] [Related]

  • 6. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Gilgado F, Serena C, Cano J, Gené J, Guarro J.
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4211-3. PubMed ID: 17015631
    [Abstract] [Full Text] [Related]

  • 7. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.
    Cuenca-Estrella M, Alastruey-Izquierdo A, Alcazar-Fuoli L, Bernal-Martinez L, Gomez-Lopez A, Buitrago MJ, Mellado E, Rodriguez-Tudela JL.
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1136-9. PubMed ID: 18195067
    [Abstract] [Full Text] [Related]

  • 8. In vitro interaction of micafungin and fluconazole against Candida.
    Rodríguez MM, Ruiz M, Pastor FJ, Quindós G, Carrillo A, Guarro J.
    J Antimicrob Chemother; 2007 Jul; 60(1):188-90. PubMed ID: 17525050
    [No Abstract] [Full Text] [Related]

  • 9. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S, Bujdáková H, Volleková A, Myoken Y, Mikami Y.
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [Abstract] [Full Text] [Related]

  • 10. In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.
    Afeltra J, Dannaoui E, Meis JF, Rodriguez-Tudela JL, Verweij PE.
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3323-6. PubMed ID: 12234872
    [Abstract] [Full Text] [Related]

  • 11. In vitro interactions of micafungin with amphotericin B against clinical isolates of Candida spp.
    Serena C, Mariné M, Quindós G, Carrillo AJ, Cano JF, Pastor FJ, Guarro J.
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1529-32. PubMed ID: 18227181
    [Abstract] [Full Text] [Related]

  • 12. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.
    Zeng J, Kamei K, Zheng Y, Nishimura K.
    Nihon Ishinkin Gakkai Zasshi; 2004 Aug; 45(2):101-4. PubMed ID: 15118667
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
    Schemuth H, Dittmer S, Lackner M, Sedlacek L, Hamprecht A, Steinmann E, Buer J, Rath PM, Steinmann J.
    Mycoses; 2013 May; 56(3):297-303. PubMed ID: 23170818
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii.
    Lackner M, Fernández-Silva F, Guarro J, Lass-Flörl C.
    J Antimicrob Chemother; 2014 Nov; 69(11):3027-32. PubMed ID: 24986494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.